MERCAPT mercaptopurine monohydrate 50 mg tablet bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

mercaptopurine monohydrate, Quantity: 50 mg

Disponible depuis:

Aspen Pharmacare Australia Pty Ltd

DCI (Dénomination commune internationale):

mercaptopurine monohydrate

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: lactose monohydrate; maize starch; stearic acid; magnesium stearate; hydrolysed maize starch

Mode d'administration:

Oral

Unités en paquet:

25 tablets

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

INDICATIONS AS AT 5 March 2004: Treatment of leukemia. It is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukemia and acute myelogenous leukemia. MERCAPT is also used in the treatment of chronic granulocytic leukaemia.

Descriptif du produit:

Visual Identification: Pale yellow, round, biconvex tablets, marked PT above the line and 50 below the line on one side and plain on the other.; Container Type: Bottle; Container Material: Glass; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Statut de autorisation:

Licence status A

Date de l'autorisation:

2017-09-21